Suboptimal prescribing of proton-pump inhibitors in low-dose aspirin users: a cohort study in primary care

被引:26
作者
de Jong, Hilda J. I. [1 ]
Korevaar, Joke C. [1 ]
van Dijk, Liset [1 ]
Voogd, Eef [1 ]
van Dijk, Christel E. [1 ]
van Oijen, Martijn G. H. [2 ,3 ]
机构
[1] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands
[2] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Los Angeles, CA 90095 USA
[3] UCLA VA Ctr Outcomes Res & Educ CORE, Dept Med, Los Angeles, CA USA
关键词
Primary Care; Gastroenterology; Preventive Medicine; EXPERT CONSENSUS DOCUMENT; FOUNDATION TASK-FORCE; GASTROINTESTINAL RISKS; GASTRODUODENAL ULCERS; CARDIOVASCULAR EVENTS; ANTIPLATELET THERAPY; PEPTIC-ULCERS; NSAID USE; PREVENTION; ACID;
D O I
10.1136/bmjopen-2013-003044
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Determine the adherence to recommendations of concomitant proton-pump inhibitor (PPI) treatment in regular low-dose of aspirin (LDASA) users, taking factors associated with the probability of receiving a PPI into account. Design Cohort study. Setting Data were obtained from 120 Dutch primary care centres participating in the Netherlands Information Network of Primary Care (LINH). Participants Patients 18years and older who were regularly prescribed LDASA (30-325mg) in 2008-2010 were included. Main outcome measures Regular medication use was defined as receiving each consecutive prescription within 6months after the previous one. Based on national guidelines, we categorised LDASA users into low and high gastrointestinal (GI) risk. A multilevel multivariable logistic regression analysis was applied to identify patient characteristics that influenced on the probability of regular PPI prescriptions. Results We identified 12343 patients who started LDASA treatment, of whom 3213 (26%) were at increased risk of GI complications. In this group, concomitant regular use of PPI was 46%, 36% did not receive PPI prescriptions and 18% obtained prescriptions irregularly (p<0.0001). The chance to obtain regularly PPI prescriptions versus no PPI was significantly influenced by, among others, previous GI complications (OR 13.9 (95% CI 11.8 to 16.4)), use of non-steroidal anti-inflammatory drugs (OR 5.2 (4.3 to 6.3)), glucocorticosteroids (6.1 (4.6 to 8.0)), selective serotonin reuptake inhibitors (9.1 (6.7 to 12.2)), drugs for functional GI disorders (2.4 (1.9 to 3.0)) and increased age. Conclusions Primary care physicians do not fully adhere to the current recommendations to prescribe PPIs regularly to LDASA users with an increased GI risk. More than 50% of the patients with an increased GI risk are not treated sufficiently with a concomitant PPI, increasing the risk of GI side effects. This finding underlines the necessity to consider merging recommendations into one common, standard and frequently used recommendation by primary care physicians.
引用
收藏
页数:9
相关论文
共 30 条
[1]   ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents [J].
Abraham, Neena S. ;
Hlatky, Mark A. ;
Antman, Elliott M. ;
Bhatt, Deepak L. ;
Bjorkman, David J. ;
Clark, Craig B. ;
Furberg, Curt D. ;
Johnson, David A. ;
Kahi, Charles J. ;
Laine, Loren ;
Mahaffey, Kenneth W. ;
Quigley, Eamonn M. ;
Scheiman, James ;
Sperling, Laurence S. ;
Tomaselli, Gordon F. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (24) :2051-2066
[2]  
[Anonymous], GLOB ATL CARD DIS PR
[3]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[4]   ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents [J].
Bhatt, Deepak L. ;
Scheiman, James ;
Abraham, Neena S. ;
Antman, Elliott M. ;
Chan, Francis K. L. ;
Furberg, Curt D. ;
Johnson, David A. ;
Mahaffey, Kenneth W. ;
Quigley, Eamonn M. .
CIRCULATION, 2008, 118 (18) :1894-1909
[5]   Gastro-protective strategies in primary care in Italy: The "Gas.Pro." survey [J].
Bianco, Maria A. ;
Rotondano, Gianluca ;
Buri, Luigi ;
Tessari, Francesco ;
Cipolletta, Livio .
DIGESTIVE AND LIVER DISEASE, 2010, 42 (05) :359-364
[6]   Indications for early aspirin use in acute ischemic stroke - A combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial [J].
Chen, ZM ;
Sandercock, P ;
Pan, HC ;
Counsell, C ;
Collins, R ;
Liu, LS ;
Xie, JX ;
Warlow, C ;
Peto, R .
STROKE, 2000, 31 (06) :1240-1249
[7]  
Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1
[8]   Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis [J].
Derry, S ;
Loke, YK .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7270) :1183-+
[9]   ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation [J].
Hamm, Christian W. ;
Bassand, Jean-Pierre ;
Agewall, Stefan ;
Bax, Jeroen ;
Boersma, Eric ;
Bueno, Hector ;
Caso, Pio ;
Dudek, Dariusz ;
Gielen, Stephan ;
Huber, Kurt ;
Ohman, Magnus ;
Petrie, Mark C. ;
Sonntag, Frank ;
Uva, Miguel Sousa ;
Storey, Robert F. ;
Wijns, William ;
Zahger, Doron .
EUROPEAN HEART JOURNAL, 2011, 32 (23) :2999-3054
[10]  
Hartnell Nicole R, 2004, Am J Geriatr Pharmacother, V2, P171, DOI 10.1016/j.amjopharm.2004.09.001